| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |